Financials

DuPont de Nemours Inc. financials

DD Chemicals

DuPont de Nemours Inc., established in 1802, is a science-based leader in advanced materials and specialty chemicals, serving sectors such as automotive, electronics, and healthcare with products like Kevlar®, Tyvek®, and Corian®. Generating annual revenues exceeding $20 billion, it leverages strong R&D investments and a robust patent portfolio to sustain high profit margins. Under the leadership of CEO Edward Breen since 2015, the company maintains a top-ten position in the global chemicals market. DuPont is actively investing in sustainable materials and digital initiatives to drive future growth while navigating industry challenges.

Snapshot

DuPont de Nemours Inc. reported $6.85B in revenue in fiscal 2025, up 1.9% year over year, with an operating margin of 7.4%.

Revenue (FY2025): $6.85B
YoY growth: +1.9%
Operating margin: 7.4%
Direction: Expanding

Financial statements

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenues	6,849,000	6,719,000	6,614,000	13,017,000
Cost of Sales	4,486,000	4,499,000	4,442,000	8,402,000
Gross Profit	2,363,000	2,220,000	2,172,000	4,615,000
Selling, General & Administrative Expenses	1,019,000	976,000	891,000	1,467,000
Depreciation & Amortization Expenses	291,000	294,000	267,000	590,000
Research & Development Expenses	193,000	203,000	192,000	536,000
Other Operating Expenses	354,000	147,000	786,000	348,000
Operating Profit	506,000	600,000	36,000	1,674,000
Interest and Investment Income	(7,000)	(6,000)	1,000	75,000
Interest Expense	(313,000)	(366,000)	(396,000)	(492,000)
Non-Operating Income	14,000	(111,000)	80,000	191,000
Total Non-Operating Income	(306,000)	(483,000)	(315,000)	(226,000)
Income Before Provision for Income Taxes	200,000	117,000	(279,000)	1,448,000
Provision for Income Taxes	102,000	213,000	(217,000)	387,000
Consolidated Net Income	98,000	(96,000)	(62,000)	1,061,000
Net Income Attributable to Minority Interests and Other	41,000	35,000	39,000	49,000
Net Income Attributable to Discontinued Operations	(836,000)	834,000	524,000	4,856,000
Net Income Attributable to Common Shareholders	(779,000)	703,000	423,000	5,868,000
Basic EPS	-1.87	1.68	0.94	2.02
Diluted EPS	-1.86	1.68	0.94	2.02
Basic Weighted Average Shares Outstanding	417,500	419,200	449,900	498,500
Diluted Weighted Average Shares Outstanding	419,200	419,200	449,900	499,400
Shares Outstanding	409,195	417,994	430,110	458,124

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Cash and Cash Equivalents	715,000	1,792,000	2,392,000	3,662,000
Short-Term Investments	—	—	—	1,302,000
Total Cash and Cash Equivalents	715,000	1,792,000	2,392,000	4,964,000
Accounts Receivable	1,669,000	1,342,000	2,370,000	2,518,000
Total Trade Receivables	1,669,000	1,342,000	2,370,000	2,518,000
Inventories	1,172,000	1,130,000	2,147,000	2,329,000
Other Current Assets	2,019,000	16,511,000	605,000	1,459,000
Total Current Assets	5,575,000	20,775,000	7,514,000	11,270,000
Net Property, Plant & Equipment	3,464,000	3,454,000	5,884,000	5,731,000
Net Intangible Assets	2,936,000	3,178,000	5,814,000	5,495,000
Goodwill	7,915,000	7,561,000	16,720,000	16,663,000
Long-Term Investments	432,000	418,000	1,071,000	733,000
Other Long-Term Assets	13,789,000	13,657,000	26,703,000	25,817,000
Total Assets	21,575,000	36,636,000	38,552,000	41,355,000
Accounts Payable	995,000	1,054,000	1,675,000	2,103,000
Accrued Expenses	882,000	784,000	1,269,000	951,000
Short-Term Debt	60,000	1,848,000	—	300,000
Other Current Liabilities	368,000	1,810,000	154,000	379,000
Total Current Liabilities	2,305,000	5,496,000	3,098,000	3,733,000
Long-Term Debt	3,134,000	5,323,000	7,800,000	7,774,000
Other Long-Term Liabilities	4,066,000	4,048,000	5,858,000	5,662,000
Total Long-Term Liabilities	7,200,000	9,371,000	13,658,000	13,436,000
Total Liabilities	7,472,000	12,843,000	13,827,000	14,338,000
Common Stock	4,000	4,000	4,000	5,000
Additional Paid-in Capital	38,718,000	47,922,000	48,059,000	48,420,000
Accumulated Other Comprehensive Income	(525,000)	(1,500,000)	(910,000)	(791,000)
Retained Earnings	(24,278,000)	(23,076,000)	(22,874,000)	(21,065,000)
Total Common Shareholders' Equity	13,919,000	23,350,000	24,279,000	26,569,000
Minority Interests and Other	184,000	443,000	446,000	448,000
Total Shareholders' Equity	14,103,000	23,793,000	24,725,000	27,017,000
Total Liabilities and Shareholders' Equity	21,575,000	36,636,000	38,552,000	41,355,000

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Net Income	98,000	(96,000)	(62,000)	1,061,000
Depreciation & Amortization	647,000	635,000	580,000	1,135,000
Share-Based Compensation Expense	38,000	56,000	57,000	75,000
Other Adjustments	90,000	111,000	477,000	(167,000)
Changes in Trade Receivables	(201,000)	(83,000)	163,000	(79,000)
Changes in Inventories	(10,000)	61,000	117,000	(215,000)
Changes in Accounts Payable	61,000	(36,000)	(232,000)	(138,000)
Changes in Other Operating Activities	689,000	1,199,000	818,000	(1,084,000)
Cash from Operating Activities	1,412,000	1,847,000	1,918,000	588,000
Capital Expenditure	(333,000)	(285,000)	(302,000)	(662,000)
Proceeds from Sale of Property, Plant & Equipment	—	(7,000)	1,236,000	10,951,000
Purchases of Investments	—	—	(32,000)	(1,317,000)
Proceeds from Sale of Investments	—	—	1,334,000	15,000
Payments for Business Acquisitions	(55,000)	(313,000)	(1,761,000)	5,000
Other Investing Activities	(299,000)	(244,000)	(336,000)	(69,000)
Cash from Investing Activities	(687,000)	(849,000)	139,000	8,923,000
Issuance of Short-Term Debt	60,000	—	—	(150,000)
Net Issuance / (Repayments) of Short-Term Debt	60,000	—	—	(150,000)
Issuance of Long-Term Debt	—	—	—	600,000
Repayments of Long-Term Debt	(4,134,000)	(687,000)	(300,000)	(3,100,000)
Net Issuance / (Repayments) of Long-Term Debt	(4,134,000)	(687,000)	(300,000)	(2,500,000)
Issuance of Common Shares	32,000	50,000	27,000	88,000
Repurchases of Common Shares	(500,000)	(500,000)	(2,000,000)	(4,375,000)
Net Issuance / (Repurchases) of Common Shares	(468,000)	(450,000)	(1,973,000)	(4,287,000)
Common Share Dividends Paid	(597,000)	(635,000)	(651,000)	(652,000)
Other Financing Activities	3,271,000	(75,000)	(65,000)	(78,000)
Cash from Financing Activities	(1,868,000)	(1,847,000)	(2,989,000)	(7,667,000)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	11,000	(62,000)	(36,000)	(148,000)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash	(1,132,000)	(911,000)	(968,000)	1,696,000

Key metrics

$16.45B

Market Cap

-21.61x

P/E

2.40x

P/S

16.58x

EV/EBITDA

0.5%

Return on Equity

1.0%

Return on Invested Capital

2.42x

Current Ratio

3.6%

Dividend Yield

15.8%

Free Cash Flow Margin

Quarterly trend

Quarter	Revenue	YoY growth	Operating margin	Operating income
Q1 2026	$1.68B	+4.3%	11.1%	$186M
Q4 2025	$-1.87B	+21.2%	29.7%	$-556M
Q3 2025	$3.07B	+7.3%	12.6%	$388M
Q2 2025	$3.26B	+2.7%	11.5%	$373M
Q1 2025	$1.61B	—	5.9%	$95M
Q4 2024	$-1.54B	—	40.6%	$-627M
Q3 2024	$2.86B	—	15.1%	$432M
Q2 2024	$3.17B	—	14.5%	$459M

Margins

34.5%

Gross margin

7.4%

Operating margin

1.4%

Net margin

Snapshot

Financial statements

Key metrics

Quarterly trend

Margins

More on DuPont de Nemours Inc.

See how VectorShift works for your firm